Tag: Lord Alton of Liverpool

The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-01-18.

To ask Her Majesty’s Government what assessment they have made of the public policy implications arising from the recent reports that one 41-year old man has fathered up to 800 children by providing his gametes to women seeking to become pregnant.

Lord Prior of Brampton

According to media reports, this particular case concerns private arrangements made between individual women seeking sperm for home insemination and the man providing the sperm. There is no third party involved. Such private arrangements between a man and a woman are not regulated. We understand that there is also no evidence to support the claim of up to 800 children having been born.

It is important that women seeking sperm donation treatment fully understand the benefits of using clinics licensed by the Human Fertilisation and Embryology Authority.

The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-01-26.

To ask Her Majesty’s Government what are the proposed protocols for (1) detection of aneuploidy in embryos following application of the proposed Augment technique, and (2) demonstrating that injected mitochondria either disperse so as to be equally inherited by each blastomere of any resulting embryos or are concentrated in the inner cell mass, in the recent application received by the Human Fertilisation and Embryology Authority (HFEA) for a pilot trial in the UK; what estimate the HFEA has been provided regarding (1) the likely financial costs to patients undergoing the proposed Augment procedure, and (2) the potential impact on clinical pregnancy rates of any assessments deemed to be scientifically necessary; and what assessment the HFEA has made of the ruling by the US Food and Drugs Administration in 2013 that Augment is a novel drug in need of extensive and expensive safety testing.

Lord Prior of Brampton

The Human Fertilisation and Embryology Authority (HFEA) advises that it does not hold data from clinics on the incidence of aneuploidy in oocytes over time, nor has it received evidence from OvaScience, Professor Simon Fishel or other sources that mitochondrial defects are primarily responsible for age-related increases in oocyte chromosomal aneuploidy.

The HFEA also advises that it has not been made aware of any published randomised trials regarding the Augment technique and has not made an assessment of the credibility of claims by OvaScience and those previously made by Clonaid, in the light of data available in peer-reviewed journals. It is currently considering whether techniques, which involve addition of autologous mitochondria to eggs, would be legal in the United Kingdom (under the framework of the Human Fertilisation and Embryology Act 1990, as amended). Part of this consideration involves considering the claims made for Augment by Ovascience.

The HFEA has not received any formal applications for clinical use of the Augment technique, and has not made an assessment of the ruling by the US Food and Drugs Administration to which the Noble Lord refers.

The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-02-10.

To ask Her Majesty’s Government under what circumstances embryonic stem cell lines that have been derived from human embryos subjected to genome editing by means of CRISPR-Cas9 would be considered to conform to good manufacturing practice and classed as clinical grade by either the Human Fertilisation and Embryology Authority or the UK Stem Cell Bank.

Lord Prior of Brampton

The Human Fertilisation and Embryology Authority (HFEA) has advised that it has licensed one human embryo research project involving the use of genome editing CRISPR-Cas9. One objective of this project is to derive human embryonic stem cells. As outlined in the HFEA Inspection Report, there is no intention for these stem cells to be used in human application. In these circumstances, there is no need to assess whether they conform to good manufacturing practice and are classed as clinical grade.

The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-02-29.

To ask Her Majesty’s Government what representations they have made to the government of the Russian Federation about the new extradition treaty signed between the Democratic People’s Republic of Korea and the Russian Federation on 2 February, and about the likely impact of the treaty’s provisions on the transfer and readmission of North Koreans who have fled their country and would be deemed to be illegally in another’s territory as a result of the treaty.

Baroness Anelay of St Johns

The Government has not made specific representations to the Government of the Russian Federation regarding this treaty.

The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-03-11.

To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 8 March (HL6323), how licence conditions R18-R27 and T97 have been specifically reflected in the patient information and consent forms submitted to the Human Fertilisation and Embryology Authority by the person responsible in order to perform genome editing in human embryos by means of CRISPR-Cas9.

Lord Prior of Brampton

The Human Fertilisation and Embryology Authority (HFEA) has advised that it carried out an audit of the patient information relating to the research project involving genome editing against the requirements of R19 and R20. T97 is not relevant, as it refers to the use of embryos in training, not research. The audit was completed as part of the inspection and feedback provided to the person responsible during the inspection. An assessment was made against the other licence conditions referred to during the inspection. The HFEA does not interpret the requirements to mean that each specific technique that might be used in the research must be specified in the patient information. In this case, the patient information, which is not yet finalised, makes it clear that genes may be altered but does not specifically refer to CRISPR-Cas9.

The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-04-12.

To ask Her Majesty’s Government whether North Korea is seen as a priority country by the Foreign and Commonwealth Office in the light of the findings of the UN Commission of Inquiry regarding wide-ranging and ongoing crimes against humanity in that country.

Baroness Anelay of St Johns

The Democratic People’s Republic of Korea (DPRK) has long been, and continues to be, a priority country for our global work on human rights and regional stability. The UK strongly supported the work of the UN Commission of Inquiry and we continue to press the North Korean regime to make tangible progress on improving its appalling human rights record. The Minister of State for Foreign and Commonwealth Affairs, my Rt Hon. Friend the Member for East Devon (Mr Swire), recently discussed DPRK and Human Rights with Ambassador Robert King, Special Envoy for Human Rights in North Korea, and Danny Russel, Assistant Secretary of State for East Asian and Pacific Affairs at the US State Department.

The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-04-21.

To ask Her Majesty’s Government what plans they have to ensure that witness statements by potential genocide survivors in Iraq and Syria are given to the International Criminal Court and that the collection of forensic evidence and the protection of mass graves is prioritised.

Baroness Anelay of St Johns

In Syria, the UK is supporting the work of non-governmental organisations who are gathering evidence of human rights violations. This is being done to the international standard required for criminal prosecution against high level perpetrators in a domestic or international court. In Iraq, we are considering how the UK might best complement similar efforts already underway with funds from other donor countries.

Cases are being prepared for international prosecution should a referral to the International Criminal Court be forthcoming or should individuals be subject to litigation by hybrid, specialised or national courts. We are therefore doing everything we can to assist in the gathering and preservation of evidence that could in future be used by judicial bodies to make a judgement on this matter. It is vital that this is done now, before evidence is lost or destroyed.

The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-05-09.

To ask Her Majesty’s Government whether they will raise with the Chinese authorities reports that North Korean agents entered Chiangbai and murdered the Korean-Chinese pastor Han Choong Yeol.

Baroness Anelay of St Johns

I refer the noble Lord to the answer given by the Minister of State for Foreign and Commonwealth Affairs, my Rt Hon. Friend the Member for East Devon (Mr Swire), to the Hon. Member for East Londonderry (Mr Campbell), on 9 May 2016 (PQ 36385), copied below for ease of reference:

‘I have no plans to raise this case with the Chinese Government. We have a regular dialogue with the Chinese about the Democratic People’s Republic of Korea (DPRK), which covers the effective implementation of UN sanctions to prevent North Korea from developing nuclear weapons, and encouraging China to confront human rights violations by the North Korean regime, most notably the important principle of non-refoulement. I raised both points with Chinese Vice Minister Chen Fengxiang in December’.

The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-05-25.

To ask Her Majesty’s Government how the Treasury ascertains that the funds of UK companies that operate in North Korea do not contribute to that country’s nuclear and ballistic missile programme or its human rights violations.

Lord O’Neill of Gatley

The Office of Financial Sanctions Implementation (OFSI) in HM Treasury is responsible for ensuring that financial sanctions, including those relating to the Democratic People’s Republic of Korea’s (North Korea), are properly understood, implemented and enforced in the United Kingdom.

OFSI is not an investigative or prosecutorial body but reviews suspected breaches of financial sanctions and then passes information to law enforcement bodies who would determine whether an investigation and or prosecution is appropriate.

The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-06-29.

To ask Her Majesty’s Government what representations they have made to the government of Iraq and the UNHCR about contingency plans for the assistance of refugees fleeing Fallujah, in particular for the provision of water, food, medicine, sanitation, and shelter.

Baroness Verma

According to the UN, 85,000 people have been displaced from Fallujah and the surrounding area since May. The UK is concerned by the humanitarian situation in the Fallujah area, including overcrowded camps and the risks posed by the extreme heat of the Iraqi summer.

The UK is working closely with UN, government and other partners to ensure that humanitarian assistance reaches people who have fled Fallujah. We call on all sides to the conflict to respect International Humanitarian Law and to ensure free, unimpeded access for humanitarian agencies.

Since June 2014, the UK has committed £79.5 million in humanitarian assistance to the crisis in Iraq. The UK is the largest contributor to the Iraq Humanitarian Pooled Fund, through which we are funding projects to support those leaving Fallujah.